Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists-Reference-Cited by-同舟云学术

Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists

Published:2018-09 Issue: Volume:104 Page:157-162
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Tanner Julie-Anne,Davies Paige E.,Voudouris Nicholas C.,Shahmirian Anashe,Herbert Deanna,Braganza Nicole,Gugila Ana,Dechairo Bryan M.,Kennedy James L.

Funder

Ministry of Research and Innovation

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference27 articles.

1. Clinical validity: combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes;Altar;Pharmacogenomics J.,2015

2. Population of US practicing psychiatrists declined, 2003-13, which may help explain poor access to mental health care;Bishop;Health Aff (Millwood),2016

3. Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools;Bousman;Pharmacogenomics J.,2018

4. Economic utility: combinatorial pharmacogenomics and medication cost savings for mental health care in a primary care setting;Brown;Clin. Therapeut.,2017

5. Psychiatry – a Recent Profile of the Profession;Canadian Collaborative Centre for Physician Resources,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose adjustment of paroxetine based on CYP2D6 activity score inferred metabolizer status in Chinese Han patients with depressive or anxiety disorders: a prospective study and cross-ethnic meta-analysis;eBioMedicine;2024-06

2. Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review;Current Treatment Options in Psychiatry;2024-05-31

3. High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing;Journal of Child and Adolescent Psychopharmacology;2024-02-01

4. Providers’ Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews;Psychiatric Services;2023-12-01

5. The psychological impact of non-responsiveness to antidepressants on patients with depression and the role of pharmacogenomics-based drug therapy;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2023-10-25